Tacrolimus
NDC 51079-817, Tacrolimus, capsule, from MylanInstitutional Inc..
- Product NDC
- 51079-817
- Status
- Listed
- Labeler
- MylanInstitutional Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090596
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51079-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TACROLIMUS.5 mg/1
Pharmacologic classes
Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51079-817-20 | 51079081720 | 100 BLISTER PACK in 1 CARTON (51079-817-20) / 1 CAPSULE in 1 BLISTER PACK (51079-817-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5f742224-618e-4f4c-bdec-7693be99c697NADAC price for package 51079081720
GET /v1/drugs/nadac/51079081720
Use it
Look up 51079-817 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51079-817 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51079-817. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.